- Recommendation ID
- DG19/1
- Question
What is the impact of using the VivaScope 1500 and 3000 imaging systems in the clinical workflow of melanoma and basal cell carcinoma assessment in secondary care in England, particularly on excision rates, diagnostic accuracy, health related quality of life and associated NHS costs?
- Any explanatory notes
(if applicable) None
Source guidance details
- Comes from guidance
- VivaScope 1500 and 3000 imaging systems for detecting skin cancer lesions
- Number
- DG19
- Date issued
- November 2015
Other details
| Is this a recommendation for the use of a technology only in the context of research? | No |
| Is it a recommendation that suggests collection of data or the establishment of a register? | No |
| Last Reviewed | 16/12/2015 |